Drug intelligence / Profile preview

palmitoyl tetrapeptide-7

Development stage
Unknown
Lead developer
Sederma
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

Palmitoyl tetrapeptide-7 is a synthetic lipopeptide composed of the amino acid sequence glycine-glutamine-proline-arginine (GQPR) attached to a palmitic acid moiety, which enhances its lipid solubility and skin penetration. It is primarily used in cosmetic and dermatological products for its anti-inflammatory and anti-aging properties. The mechanism of action involves reducing the production of interleukin 6 (IL‑6), a pro-inflammatory cytokine that accelerates collagen breakdown and skin aging. By decreasing IL‑6 levels, it helps slow down collagen degradation, reduce inflammation, promote synthesis of type I collagen, fibronectin, and hyaluronic acid, leading to improved skin elasticity and reduced appearance of wrinkles. It is often used in combination with other peptides such as palmitoyl tripeptide‑1 in formulations like Matrixyl 3000[1][2][3][4][5][6].

Other names
palmitoyl tetrapeptide-3N-palmitoylrigin
02

Targets

IL-6 (Interleukin 6)

Beyond the preview

Go deeper on palmitoyl tetrapeptide-7.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on palmitoyl tetrapeptide-7.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call